— Know what they know.
Not Investment Advice

Financial News

Sentiment -60.9 4704 articles 2162 bullish 1273 bearish Full Index →
📰

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data
📰

Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

CAMBRIDGE, Mass., March 24, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today...
📰

BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Biomea Fusion Reports Full Year 2025 Financial Results and Corporate Highlights

Initiated two Phase II trials COVALENT-211 and COVALENT-212 (icovamenib in type 2 diabetes) with 26-week primary endpoint data anticipated in the...
📰

Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results

LONG BEACH, Calif and TORONTO, March 24, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U)...
📰

Glass House Brands Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth quarter and full year results reflect temporary planned scale back in wholesale production At year-end was back to fully planted with legacy...
📰

BioCardia Reports 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for...
📰

PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results

PRINCETON, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage...
📰

Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026 Received favorable FDA feedback on De Novo...
📰

Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026
📰

BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Overstating Electrophysiology Growth Projections: Levi & Korsinsky

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>NEW...
📰

Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win

Focused on therapies for rare skin diseases, this clinical-stage biotech saw a notable director purchase coincide with a decisive Phase 3 trial...
UnitedHealth Group Incorporated $UNH Stock Position Raised b

UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.

Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised b

UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.

Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised b

UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.

Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised b

UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.

Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
📰

Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Bill Few Associates Inc. Purchases 7,522 Shares of Abbott La

Bill Few Associates Inc. Purchases 7,522 Shares of Abbott Laboratories $ABT

Bill Few Associates Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.0% in the fourth quarter,...
Bill Few Associates Inc. Purchases 7,522 Shares of Abbott La

Bill Few Associates Inc. Purchases 7,522 Shares of Abbott Laboratories $ABT

Bill Few Associates Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.0% in the fourth quarter,...
Assenagon Asset Management S.A. Increases Position in Abbott

Assenagon Asset Management S.A. Increases Position in Abbott Laboratories $ABT

Assenagon Asset Management S.A. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 333.5% during the 4th...
Assenagon Asset Management S.A. Increases Position in Abbott

Assenagon Asset Management S.A. Increases Position in Abbott Laboratories $ABT

Assenagon Asset Management S.A. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 333.5% during the 4th...
Clear Trail Advisors LLC Makes New $7.97 Million Investment

Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK

Clear Trail Advisors LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to...
Clear Trail Advisors LLC Makes New $7.97 Million Investment

Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK

Clear Trail Advisors LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to...
Congress Asset Management Co. Has $178.14 Million Stock Posi

Congress Asset Management Co. Has $178.14 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Congress Asset Management Co. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.6% in the 4th...
Capital Asset Advisory Services LLC Sells 1,295 Shares of Th

Capital Asset Advisory Services LLC Sells 1,295 Shares of Thermo Fisher Scientific Inc. $TMO

Capital Asset Advisory Services LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.1% during...
Capital Asset Advisory Services LLC Sells 1,295 Shares of Th

Capital Asset Advisory Services LLC Sells 1,295 Shares of Thermo Fisher Scientific Inc. $TMO

Capital Asset Advisory Services LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.1% during...
Congress Asset Management Co. Has $178.14 Million Stock Posi

Congress Asset Management Co. Has $178.14 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Congress Asset Management Co. reduced its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1.6% in the 4th...
Capital Asset Advisory Services LLC Sells 1,295 Shares of Th

Capital Asset Advisory Services LLC Sells 1,295 Shares of Thermo Fisher Scientific Inc. $TMO

Capital Asset Advisory Services LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.1% during...
Amgen Inc. $AMGN Shares Sold by Diversified Trust Co.

Amgen Inc. $AMGN Shares Sold by Diversified Trust Co.

Diversified Trust Co. lessened its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.5% in the 4th quarter, according to its most recent...
Amgen Inc. $AMGN Shares Sold by Diversified Trust Co.

Amgen Inc. $AMGN Shares Sold by Diversified Trust Co.

Diversified Trust Co. lessened its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.5% in the 4th quarter, according to its most recent...
Urgent Loans with Guaranteed Approval and No Credit Check fo

Urgent Loans with Guaranteed Approval and No Credit Check for Bad Credit Consumers Announced by Honest Loans for 2026

Boulder, CO, March 24, 2026 (GLOBE NEWSWIRE) --  Honest Loans today announced the launch of its 2026 lending initiative, introducing expanded...
E. Ohman J or Asset Management AB Boosts Stock Holdings in B

E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX

E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
E. Ohman J or Asset Management AB Boosts Stock Holdings in B

E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX

E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
E. Ohman J or Asset Management AB Boosts Stock Holdings in B

E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX

E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
📰

Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF

The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and yields 3.3%.
📰

Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF

The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and yields 3.3%.
Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Up

Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Upside Target

Ondas Inc. (NASDAQ:ONDS) delivered record quarterly results on Monday, sharply boosting its 2026 outlook and winning an analyst price-target hike on...
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position

AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position

BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 28.9% during the fourth quarter, according to the company in its most...
Community Trust & Investment Co. Lowers Position in Zoetis I

Community Trust & Investment Co. Lowers Position in Zoetis Inc. $ZTS

Community Trust & Investment Co. trimmed its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 25.6% during the fourth...
Community Trust & Investment Co. Lowers Position in Zoetis I

Community Trust & Investment Co. Lowers Position in Zoetis Inc. $ZTS

Community Trust & Investment Co. trimmed its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 25.6% during the fourth...
Zoetis Inc. $ZTS Shares Purchased by Central Bank & Trust Co

Zoetis Inc. $ZTS Shares Purchased by Central Bank & Trust Co.

Central Bank & Trust Co. raised its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 54.3% in the fourth quarter, according...
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position

AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position

BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 28.9% during the fourth quarter, according to the company in its most...
« Prev 1 38 39 40 41 42 83 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms